Homet Moreno, B.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

Hugo, Willy, Zaretsky, Jesse M., Sun, Lu, Song, Chunying, Moreno, Blanca Homet, Hu-Lieskovan, Siwen, Berent-Maoz, Beata, Pang, Jia, Chmielowski, Bartosz, Cherry, Grace, Seja, Elizabeth, Lomeli, Shirle

Journal:

Year:

2017

Language:

english

File:

PDF, 63 KB

english, 2017

2

Tyrosine kinase inhibitors in treating soft tissue sarcomas: sunitinib in non-GIST sarcomas

Blanca Homet Moreno, Elena Garralda Cabanas, Ricardo Hitt

Journal:

Clinical and Translational Oncology

Year:

2010

Language:

english

File:

PDF, 142 KB

english, 2010

3

1246 Oral oncology drugs: how do patients view their effectiveness?

B. Homet Moreno, R. Hitt, I. Ghanem, D. Malon, H. Cortes-Funes

Journal:

European Journal of Cancer Supplements

Year:

2009

Language:

english

File:

PDF, 49 KB

english, 2009

4

7038 Oral vinorelbine as a fixed-weekly schedule in taxanes-refractory advanced HRPC. A single institution experience

Rodriguez, A., Iglesias, L., Sepulveda, J., Sanchez, L. Garcia, Cortijo, A., Escobar, I. Garcia, Cañete, I. Ghanem, Moreno, B. Homet, Antolin, A. Rodriguez, Castellano, D.

Journal:

European Journal of Cancer Supplements

Year:

2009

Language:

english

File:

PDF, 67 KB

english, 2009

5

7152 Efficacy of Olmesartan Medoxomil for hypertension control in advanced RCC patients under treatment with single agent Sunitinib

Castellano, D., Garcia-Donaire, J.A., Sepulveda, J., Pereira, S., Rodriguez, A., Iglesias, L., Escobar, I. Garcia, Cañete, I. Ghanem, Moreno, B. Homet, Cortes-Funes, H.

Journal:

European Journal of Cancer Supplements

Year:

2009

Language:

english

File:

PDF, 48 KB

english, 2009

6

Combining Targeted Therapy With Immunotherapy in BRAF-Mutant Melanoma: Promise and Challenges

Hu-Lieskovan, S., Robert, L., Homet Moreno, B., Ribas, A.

Journal:

Journal of Clinical Oncology

Year:

2014

Language:

english

File:

PDF, 194 KB

english, 2014

7

Anti–PD-1 Therapy in Melanoma

Homet Moreno, Blanca, Parisi, Giulia, Robert, Lidia, Ribas, Antoni

Journal:

Seminars in Oncology

Year:

2015

Language:

english

File:

PDF, 798 KB

english, 2015

8

Anti-programmed cell death protein-1/ligand-1 therapy in different cancers

Homet Moreno, B, Ribas, A

Journal:

British Journal of Cancer

Year:

2015

Language:

english

File:

PDF, 240 KB

english, 2015

9

Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAFV600E melanoma

Hu-Lieskovan, S., Mok, S., Homet Moreno, B., Tsoi, J., Robert, L., Goedert, L., Pinheiro, E. M., Koya, R. C., Graeber, T. G., Comin-Anduix, B., Ribas, A.

Journal:

Science Translational Medicine

Year:

2015

Language:

english

File:

PDF, 2.55 MB

english, 2015

10

Excluding T Cells: Is β-Catenin the Full Story?

Hu-Lieskovan, Siwen, Homet Moreno, Blanca, Ribas, Antoni

Journal:

Year:

2015

Language:

english

File:

PDF, 179 KB

english, 2015

11

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

Hugo, Willy, Zaretsky, Jesse M., Sun, Lu, Song, Chunying, Moreno, Blanca Homet, Hu-Lieskovan, Siwen, Berent-Maoz, Beata, Pang, Jia, Chmielowski, Bartosz, Cherry, Grace, Seja, Elizabeth, Lomeli, Shirle

Journal:

Year:

2016

Language:

english

File:

PDF, 2.60 MB

english, 2016

12

Combined Treatment with Dabrafenib and Trametinib with Immune-stimulating Antibodies for BRAF Mutant Melanoma

Homet Moreno, Blanca, Mok, Stephen, Comin-Anduix, Begonya, Hu-Lieskovan, Siwen, Ribas, Antoni

Journal:

Year:

2015

Language:

english

File:

PDF, 3.02 MB

english, 2015

13

Response to programmed cell death-1 blockade in a murine melanoma syngeneic model requires costimulation, CD4, and CD8 T cells

Homet Moreno, B., Zaretsky, J. M., Garcia-Diaz, A., Tsoi, J., Parisi, G., Robert, L., Meeth, K., Ndoye, A., Bosenberg, M. W., Weeraratna, A. T., Graeber, T. G., Comin-Anduix, B., Hu-Lieskovan, S., Rib

Journal:

Cancer Immunology Research

Year:

2016

Language:

english

File:

PDF, 1.99 MB

english, 2016

14

Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression

Garcia-Diaz, Angel, Shin, Daniel Sanghoon, Moreno, Blanca Homet, Saco, Justin, Escuin-Ordinas, Helena, Rodriguez, Gabriel Abril, Zaretsky, Jesse M., Sun, Lu, Hugo, Willy, Wang, Xiaoyan, Parisi, Giulia

Journal:

Year:

2017

Language:

english

File:

PDF, 4.64 MB

english, 2017

15

Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance

Su, Yapeng, Wei, Wei, Robert, Lidia, Xue, Min, Tsoi, Jennifer, Garcia-Diaz, Angel, Homet Moreno, Blanca, Kim, Jungwoo, Ng, Rachel H., Lee, Jihoon W., Koya, Richard C., Comin-Anduix, Begonya, Graeber,

Journal:

Proceedings of the National Academy of Sciences

Year:

2017

Language:

english

File:

PDF, 1.42 MB

english, 2017

16

1216OKEYNOTE-022 update: phase 1 study of first-line pembrolizumab (pembro) plus dabrafenib (D) and trametinib (T) for BRAF-mutant advanced melanoma

Ribas, A., Hodi, F.S., Lawrence, D., Atkinson, V., Agarwal, S., Carlino, M.S., Fisher, R., Long, G.V., Miller, W.H., Huang, Y., Homet Moreno, B., Ibrahim, N., Hamid, O.

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 79 KB

english, 2017

17

Isolation and characterization of NY-ESO-1–specific T cell receptors restricted on various MHC molecules

Bethune, Michael T., Li, Xiao-Hua, Yu, Jiaji, McLaughlin, Jami, Cheng, Donghui, Mathis, Colleen, Moreno, Blanca Homet, Woods, Katherine, Knights, Ashley J., Garcia-Diaz, Angel, Wong, Stephanie, Hu-Lie

Journal:

Proceedings of the National Academy of Sciences

Year:

2018

Language:

english

File:

PDF, 2.38 MB

english, 2018

18

1257TiPKEYNOTE 029: Phase 1/2 randomized study of pembrolizumab (pembro) plus 2 dose regimens of ipilimumab (ipi) for advanced melanoma

Atkins, M.B., Carlino, M.S., Hill, A.G., McNeil, C.M., Ribas, A., Atkinson, V., Cebon, J.S., Jameson, M.B., Hwu, W-J., Thompson, J.A., Anderson, J., Homet Moreno, B., Ibrahim, N., Long, G.V.

Journal:

Annals of Oncology

Year:

2017

File:

PDF, 76 KB

2017

19

1257TiPKEYNOTE 029: Phase 1/2 randomized study of pembrolizumab (pembro) plus 2 dose regimens of ipilimumab (ipi) for advanced melanoma

Atkins, M.B., Carlino, M.S., Hill, A.G., McNeil, C.M., Ribas, A., Atkinson, V., Cebon, J.S., Jameson, M.B., Hwu, W-J., Thompson, J.A., Anderson, J., Homet Moreno, B., Ibrahim, N., Long, G.V.

Journal:

Annals of Oncology

Year:

2017

Language:

english

File:

PDF, 76 KB

english, 2017

20

1375TiPPembrolizumab (pembro) plus lenvatinib (len) for first-line treatment of patients (pts) with advanced melanoma: Phase III LEAP-003 study

Eggermont, A M M, Carlino, M S, Hauschild, A, Ascierto, P A, Arance, A, Daud, A, O’Day, S J, Taylor, M H, Smith, A, Rodgers, A, Moreno, B Homet, Diede, S J, Kluger, H

Journal:

Annals of Oncology

Year:

2019

File:

PDF, 79 KB

2019

21

Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression

Garcia-Diaz, Angel, Shin, Daniel Sanghoon, Moreno, Blanca Homet, Saco, Justin, Escuin-Ordinas, Helena, Rodriguez, Gabriel Abril, Zaretsky, Jesse M., Sun, Lu, Hugo, Willy, Wang, Xiaoyan, Parisi, Giulia

Journal:

Year:

2019

File:

PDF, 142 KB

2019

22

The cost effectiveness of pembrolizumab versus chemotherapy or atezolizumab as second-line therapy for advanced urothelial carcinoma in the United States

Slater, Rachael Louise, Lai, Yizhen, Zhong, Yichen, Li, Haojie, Meng, Yang, Homet Moreno, Blanca, Godwin, James Luke, Frenkl, Tara, Sonpavde, Guru P, Mamtani, Ronac

Journal:

Journal of Medical Economics

Year:

2020

File:

PDF, 838 KB

2020

23

Cost-effectiveness of Pembrolizumab versus Carboplatin-based Chemotherapy as First-line Treatment of PD-L1âpositive Locally Advanced or Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Therapy in the United States

Hale, Oliver, Patterson, Karl, Lai, Yizhen, Meng, Yang, Li, Haojie, Godwin, James Luke, Homet Moreno, Blanca, Mamtani, Ronac

Journal:

Clinical Genitourinary Cancer

Year:

2020

File:

PDF, 813 KB

2020